Alexander Panossian

Pharmacy — Finnish Institute for Health and Welfare, Finland

LeadR Profile

Alexander Panossian Finnish Institute for Health and Welfare Finland
320 ScienceLeadR Reputation 320
Network Map

Pharmacy

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1975 - 2021

Source: PubMed

Finnish Institute for Health and Welfare

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 66

Citations

Citations: 4 174 1st author: 29 Last author: 24 Unique author: 7


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Trends and Pitfalls in the Progress of Network Pharmacology Research on Natural Products.
pharmacology, research
Pharmaceuticals (Basel)20250
Adaptogens in Long-Lasting Brain Fatigue: An Insight from Systems Biology and Network Pharmacology.
cells, genes, neurogenesis, stroke, mental fatigue, homeostasis, stress, physiological, brain, systems biology, epinephrine, fatigue, pharmacology, tissues, wounds and injuries, infections, virus diseases
Pharmaceuticals (Basel)20251
State-of-the-Art Review on Botanical Hybrid Preparations in Phytomedicine and Phytotherapy Research: Background and Perspectives.
pharmacology, phytotherapy, carnosine, research, gene expression
Pharmaceuticals (Basel)202411
Efficacy of Kan Jang in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial.
infections, pain, fatigue, headache, pharynx, interleukin-6, c-reactive protein, nose, quality of life, blood, cough, muscles, covid-19, sars-cov-2
Pharmaceuticals (Basel)20232
Challenges in phytotherapy research.
phytotherapy, research
Front Pharmacol202324

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 1 1
Phase 2/Phase 3 1

By status:

Not yet recruiting 1
Unknown 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Effect of Gamma cyclodextrin on the Bioavailability of Berberine
NCT04918667 — biological availability, pharmaceutical preparations, healthy volunteers, capsules, cyclodextrins, berberine, absorption, plasma
Phase 1Not yet recruiting2024

LeadR Networks

Main global connection map